Tirzepatide: a new glucagon-like peptide for patients with diabetes II
By: Hannah Grice, PharmD In the United States, 34.2 million people have diabetes,1 the majority of them have type II diabetes. Type II diabetes is a chronic disease characterized by elevated blood glucose. Management of type II diabetes is multifactorial: diet, exercise, and pharmacotherapy are all part of the treatment. Recently, a new medication called […]